https://stock.noler.com/us/stock/chemocentryx-inc https://stock.noler.com/us/stock/chemocentryx-inc/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/chemocentryx-inc/accounts-payable https://stock.noler.com/us/stock/chemocentryx-inc/accounts-receivable https://stock.noler.com/us/stock/chemocentryx-inc/accounts-receivable-related-parties https://stock.noler.com/us/stock/chemocentryx-inc/accounts-receivable-related-parties-current https://stock.noler.com/us/stock/chemocentryx-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/chemocentryx-inc/accrued-advertising-current-and-noncurrent https://stock.noler.com/us/stock/chemocentryx-inc/accrued-liabilities-current https://stock.noler.com/us/stock/chemocentryx-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/chemocentryx-inc/accumulated-depreciation https://stock.noler.com/us/stock/chemocentryx-inc/accumulated-depreciation-excluding-capital-leased-assets https://stock.noler.com/us/stock/chemocentryx-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/chemocentryx-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/chemocentryx-inc/additional-paid-in-capital https://stock.noler.com/us/stock/chemocentryx-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/chemocentryx-inc/adjustments-related-to-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/chemocentryx-inc/advertising-expense https://stock.noler.com/us/stock/chemocentryx-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/chemocentryx-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/chemocentryx-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/chemocentryx-inc/aoci https://stock.noler.com/us/stock/chemocentryx-inc/asset-impairment-charges https://stock.noler.com/us/stock/chemocentryx-inc/assets-fair-value-disclosure https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-and-held-to-maturity-securities https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-current https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-debt-current https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-debt-noncurrent https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-debt-unrealized-gain-loss https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-debt-unrealized-loss-position-12-months-or-longer-number-of-positions https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-fair-value-disclosure https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-gross-realized-gain-loss-net https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-gross-unrealized-gain https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-gross-unrealized-gain-loss https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-gross-unrealized-gain-loss-1 https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-gross-unrealized-losses https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-in-unrealized-loss-positions-qualitative-disclosure-number-of-positions-greater-than-or-equal-to-one-year https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-noncurrent https://stock.noler.com/us/stock/chemocentryx-inc/available-for-sale-securities https://stock.noler.com/us/stock/chemocentryx-inc/basic-shares https://stock.noler.com/us/stock/chemocentryx-inc/capital-expenditures https://stock.noler.com/us/stock/chemocentryx-inc/capital-lease-obligations https://stock.noler.com/us/stock/chemocentryx-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/chemocentryx-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/chemocentryx-inc/cash https://stock.noler.com/us/stock/chemocentryx-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/chemocentryx-inc/cash-and-cash-equivalents-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/chemocentryx-inc/cash-and-cash-equivalents-fair-value-disclosure https://stock.noler.com/us/stock/chemocentryx-inc/cash-and-equivalents https://stock.noler.com/us/stock/chemocentryx-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/chemocentryx-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/chemocentryx-inc/cash-flow-breakdown https://stock.noler.com/us/stock/chemocentryx-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/chemocentryx-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/chemocentryx-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/chemocentryx-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/chemocentryx-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/chemocentryx-inc/common-stock-value https://stock.noler.com/us/stock/chemocentryx-inc/comprehensive-income https://stock.noler.com/us/stock/chemocentryx-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/chemocentryx-inc/contract-with-customer-performance-obligation-satisfied-in-previous-period https://stock.noler.com/us/stock/chemocentryx-inc/contractual-obligation https://stock.noler.com/us/stock/chemocentryx-inc/convertible-debt https://stock.noler.com/us/stock/chemocentryx-inc/convertible-debt-fair-value-disclosures https://stock.noler.com/us/stock/chemocentryx-inc/convertible-long-term-notes-payable https://stock.noler.com/us/stock/chemocentryx-inc/convertible-notes-payable https://stock.noler.com/us/stock/chemocentryx-inc/convertible-preferred-stock-shares-issued-upon-conversion https://stock.noler.com/us/stock/chemocentryx-inc/costs-and-expenses https://stock.noler.com/us/stock/chemocentryx-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/chemocentryx-inc/cumulative-effect-on-retained-earnings-net-of-tax https://stock.noler.com/us/stock/chemocentryx-inc/current-assets https://stock.noler.com/us/stock/chemocentryx-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/chemocentryx-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/chemocentryx-inc/current-liabilities https://stock.noler.com/us/stock/chemocentryx-inc/current-portion-of-long-term-debt https://stock.noler.com/us/stock/chemocentryx-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/chemocentryx-inc/debt-basis-spread-on-variable-rate https://stock.noler.com/us/stock/chemocentryx-inc/debt-carrying-amount https://stock.noler.com/us/stock/chemocentryx-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/chemocentryx-inc/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/chemocentryx-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/chemocentryx-inc/debt-convertible-effective-interest-rate https://stock.noler.com/us/stock/chemocentryx-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/chemocentryx-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/chemocentryx-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/chemocentryx-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/chemocentryx-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/chemocentryx-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/chemocentryx-inc/debt-maturing-remainder-of-fiscal-year https://stock.noler.com/us/stock/chemocentryx-inc/debt-repaid https://stock.noler.com/us/stock/chemocentryx-inc/debt-unamortized-discount https://stock.noler.com/us/stock/chemocentryx-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/chemocentryx-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/chemocentryx-inc/deferred-income-tax-liabilities-net https://stock.noler.com/us/stock/chemocentryx-inc/deferred-revenue https://stock.noler.com/us/stock/chemocentryx-inc/deferred-revenue-2 https://stock.noler.com/us/stock/chemocentryx-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/chemocentryx-inc/deferred-revenue-recognized https://stock.noler.com/us/stock/chemocentryx-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/chemocentryx-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/chemocentryx-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/chemocentryx-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/chemocentryx-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/chemocentryx-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/chemocentryx-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/chemocentryx-inc/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/chemocentryx-inc/deferred-tax-assets-operating-loss-carryforwards-subject-to-expiration https://stock.noler.com/us/stock/chemocentryx-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/chemocentryx-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/chemocentryx-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/chemocentryx-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/chemocentryx-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-reserves https://stock.noler.com/us/stock/chemocentryx-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/chemocentryx-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/chemocentryx-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/chemocentryx-inc/depreciation https://stock.noler.com/us/stock/chemocentryx-inc/diluted-shares https://stock.noler.com/us/stock/chemocentryx-inc/dividends-payable-current-and-noncurrent https://stock.noler.com/us/stock/chemocentryx-inc/due-from-related-parties-current https://stock.noler.com/us/stock/chemocentryx-inc/due-to-other-related-parties-classified-current https://stock.noler.com/us/stock/chemocentryx-inc/due-to-related-parties-noncurrent https://stock.noler.com/us/stock/chemocentryx-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/chemocentryx-inc/effective-tax-rate https://stock.noler.com/us/stock/chemocentryx-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/chemocentryx-inc/eps https://stock.noler.com/us/stock/chemocentryx-inc/eps-basic https://stock.noler.com/us/stock/chemocentryx-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/chemocentryx-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/chemocentryx-inc/financing-cash-flow https://stock.noler.com/us/stock/chemocentryx-inc/general-and-administrative-expense https://stock.noler.com/us/stock/chemocentryx-inc/grants-receivable https://stock.noler.com/us/stock/chemocentryx-inc/income-tax https://stock.noler.com/us/stock/chemocentryx-inc/increase-decrease-in-accounts-and-other-receivables https://stock.noler.com/us/stock/chemocentryx-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/chemocentryx-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/chemocentryx-inc/increase-decrease-in-accounts-receivable-related-parties https://stock.noler.com/us/stock/chemocentryx-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/chemocentryx-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/chemocentryx-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/chemocentryx-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/chemocentryx-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/chemocentryx-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/chemocentryx-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/chemocentryx-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/chemocentryx-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/chemocentryx-inc/insider-transactions-other https://stock.noler.com/us/stock/chemocentryx-inc/insider-transactions-preferred https://stock.noler.com/us/stock/chemocentryx-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/chemocentryx-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/chemocentryx-inc/insider-transactions-warrants https://stock.noler.com/us/stock/chemocentryx-inc/interest-expense https://stock.noler.com/us/stock/chemocentryx-inc/interest-expense-on-debt https://stock.noler.com/us/stock/chemocentryx-inc/interest-expense-other https://stock.noler.com/us/stock/chemocentryx-inc/interest-income-expense-net https://stock.noler.com/us/stock/chemocentryx-inc/interest-paid https://stock.noler.com/us/stock/chemocentryx-inc/interest-paid-net https://stock.noler.com/us/stock/chemocentryx-inc/inventory https://stock.noler.com/us/stock/chemocentryx-inc/investing-cash-flow https://stock.noler.com/us/stock/chemocentryx-inc/investment-income-interest https://stock.noler.com/us/stock/chemocentryx-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/chemocentryx-inc/lease-and-rental-expense https://stock.noler.com/us/stock/chemocentryx-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/chemocentryx-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/chemocentryx-inc/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/chemocentryx-inc/license-and-services-revenue https://stock.noler.com/us/stock/chemocentryx-inc/line-of-credit https://stock.noler.com/us/stock/chemocentryx-inc/line-of-credit-facility-amount-outstanding https://stock.noler.com/us/stock/chemocentryx-inc/line-of-credit-facility-interest-rate https://stock.noler.com/us/stock/chemocentryx-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/chemocentryx-inc/long-term-debt https://stock.noler.com/us/stock/chemocentryx-inc/long-term-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/chemocentryx-inc/long-term-debt-fair-value https://stock.noler.com/us/stock/chemocentryx-inc/long-term-investments https://stock.noler.com/us/stock/chemocentryx-inc/maturities-of-available-for-sale-securities https://stock.noler.com/us/stock/chemocentryx-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/chemocentryx-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/chemocentryx-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/chemocentryx-inc/net-change-in-cash https://stock.noler.com/us/stock/chemocentryx-inc/net-income https://stock.noler.com/us/stock/chemocentryx-inc/number-of-operating-segments https://stock.noler.com/us/stock/chemocentryx-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/chemocentryx-inc/oci-available-for-sale-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/chemocentryx-inc/oci-available-for-sale-adjustment-net-of-tax-change https://stock.noler.com/us/stock/chemocentryx-inc/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-net-of-tax https://stock.noler.com/us/stock/chemocentryx-inc/oci-reclassification-adjustment-from-aoci-for-sale-of-securities-tax https://stock.noler.com/us/stock/chemocentryx-inc/operating-cash-flow https://stock.noler.com/us/stock/chemocentryx-inc/operating-income https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-assets https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-cost https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-expense https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-liability https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-liability-current https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-payments https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-payments-due https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-variable-lease-income https://stock.noler.com/us/stock/chemocentryx-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/chemocentryx-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/chemocentryx-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/chemocentryx-inc/other-income https://stock.noler.com/us/stock/chemocentryx-inc/other-noncash-expense https://stock.noler.com/us/stock/chemocentryx-inc/other-noncash-income-expense https://stock.noler.com/us/stock/chemocentryx-inc/other-noncurrent-assets https://stock.noler.com/us/stock/chemocentryx-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/chemocentryx-inc/other-nonoperating-income https://stock.noler.com/us/stock/chemocentryx-inc/other-than-temporary-impairment-losses-investments-available-for-sale-securities https://stock.noler.com/us/stock/chemocentryx-inc/paid-in-capital-equity-component-of-convertible-debt https://stock.noler.com/us/stock/chemocentryx-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/chemocentryx-inc/payments-for-proceeds-from-tenant-allowance https://stock.noler.com/us/stock/chemocentryx-inc/payments-to-acquire-available-for-sale-debt https://stock.noler.com/us/stock/chemocentryx-inc/payments-to-acquire-available-for-sale-securities https://stock.noler.com/us/stock/chemocentryx-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/chemocentryx-inc/preferred-shares-facts https://stock.noler.com/us/stock/chemocentryx-inc/preferred-stock-liquidation-preference-value https://stock.noler.com/us/stock/chemocentryx-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/chemocentryx-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/chemocentryx-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/chemocentryx-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/chemocentryx-inc/preferred-stock-value https://stock.noler.com/us/stock/chemocentryx-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/chemocentryx-inc/pretax-income https://stock.noler.com/us/stock/chemocentryx-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/chemocentryx-inc/proceeds-from-debt-net-of-issuance-costs https://stock.noler.com/us/stock/chemocentryx-inc/proceeds-from-income-tax-refunds https://stock.noler.com/us/stock/chemocentryx-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/chemocentryx-inc/proceeds-from-issuance-of-shares-under-incentive-and-share-based-compensation-plans-including-stock-options https://stock.noler.com/us/stock/chemocentryx-inc/proceeds-from-lines-of-credit https://stock.noler.com/us/stock/chemocentryx-inc/proceeds-from-long-term-capital-lease-obligations https://stock.noler.com/us/stock/chemocentryx-inc/proceeds-from-sale-maturity-and-collections-of-investments https://stock.noler.com/us/stock/chemocentryx-inc/proceeds-from-sale-of-available-for-sale-debt https://stock.noler.com/us/stock/chemocentryx-inc/proceeds-from-sale-of-available-for-sale-securities https://stock.noler.com/us/stock/chemocentryx-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/chemocentryx-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/chemocentryx-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/chemocentryx-inc/profit-loss https://stock.noler.com/us/stock/chemocentryx-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/chemocentryx-inc/property-plant-equipment https://stock.noler.com/us/stock/chemocentryx-inc/public-float https://stock.noler.com/us/stock/chemocentryx-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/chemocentryx-inc/repayments-of-secured-debt https://stock.noler.com/us/stock/chemocentryx-inc/research-and-development https://stock.noler.com/us/stock/chemocentryx-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/chemocentryx-inc/retained-earnings https://stock.noler.com/us/stock/chemocentryx-inc/revenue https://stock.noler.com/us/stock/chemocentryx-inc/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/chemocentryx-inc/revenue-from-contract-with-customer-including-assessed-tax https://stock.noler.com/us/stock/chemocentryx-inc/revenue-from-grants https://stock.noler.com/us/stock/chemocentryx-inc/revenue-from-related-parties https://stock.noler.com/us/stock/chemocentryx-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/chemocentryx-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/chemocentryx-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/chemocentryx-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/chemocentryx-inc/sec-filings-10-k https://stock.noler.com/us/stock/chemocentryx-inc/sec-filings-10-q https://stock.noler.com/us/stock/chemocentryx-inc/sec-filings-15-12g https://stock.noler.com/us/stock/chemocentryx-inc/sec-filings-25-nse https://stock.noler.com/us/stock/chemocentryx-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/chemocentryx-inc/sec-filings-8-k https://stock.noler.com/us/stock/chemocentryx-inc/sec-filings-ars https://stock.noler.com/us/stock/chemocentryx-inc/sec-filings-certnas https://stock.noler.com/us/stock/chemocentryx-inc/sec-filings-ct-order https://stock.noler.com/us/stock/chemocentryx-inc/sec-filings-def-14a https://stock.noler.com/us/stock/chemocentryx-inc/sec-filings-defa14a https://stock.noler.com/us/stock/chemocentryx-inc/sec-filings-defm14a https://stock.noler.com/us/stock/chemocentryx-inc/sec-filings-prem14a https://stock.noler.com/us/stock/chemocentryx-inc/sec-filings-regdex https://stock.noler.com/us/stock/chemocentryx-inc/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/chemocentryx-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/chemocentryx-inc/secondary-offerings-form-del-am https://stock.noler.com/us/stock/chemocentryx-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/chemocentryx-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/chemocentryx-inc/secondary-offerings-form-posasr https://stock.noler.com/us/stock/chemocentryx-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/chemocentryx-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/chemocentryx-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/chemocentryx-inc/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/chemocentryx-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/chemocentryx-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/chemocentryx-inc/secured-debt-current https://stock.noler.com/us/stock/chemocentryx-inc/secured-long-term-debt https://stock.noler.com/us/stock/chemocentryx-inc/sga-expense https://stock.noler.com/us/stock/chemocentryx-inc/share-based-goods-and-nonemployee-services-transaction-expense https://stock.noler.com/us/stock/chemocentryx-inc/share-based-goods-and-nonemployee-services-transaction-quantity-of-securities-issued https://stock.noler.com/us/stock/chemocentryx-inc/share-based-goods-and-nonemployee-services-transaction-valuation-method-expected-dividend-rate https://stock.noler.com/us/stock/chemocentryx-inc/share-based-goods-and-nonemployee-services-transaction-valuation-method-expected-volatility-rate https://stock.noler.com/us/stock/chemocentryx-inc/share-based-goods-and-nonemployee-services-transaction-valuation-method-risk-free-interest-rate https://stock.noler.com/us/stock/chemocentryx-inc/share-price https://stock.noler.com/us/stock/chemocentryx-inc/shareholders-equity https://stock.noler.com/us/stock/chemocentryx-inc/shares-authorized https://stock.noler.com/us/stock/chemocentryx-inc/shares-issued https://stock.noler.com/us/stock/chemocentryx-inc/short-term-investments https://stock.noler.com/us/stock/chemocentryx-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/chemocentryx-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/chemocentryx-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/chemocentryx-inc/stock-award-number-of-additional-shares-authorized https://stock.noler.com/us/stock/chemocentryx-inc/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/chemocentryx-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/chemocentryx-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/chemocentryx-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/chemocentryx-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/chemocentryx-inc/stock-award-plan-modification-incremental-compensation-cost https://stock.noler.com/us/stock/chemocentryx-inc/stock-award-shares-issued-in-period https://stock.noler.com/us/stock/chemocentryx-inc/stock-based-compensation https://stock.noler.com/us/stock/chemocentryx-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/chemocentryx-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/chemocentryx-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/chemocentryx-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/chemocentryx-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/chemocentryx-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/chemocentryx-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/chemocentryx-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/chemocentryx-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/chemocentryx-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/chemocentryx-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/chemocentryx-inc/stock-options-forfeitures-and-expirations-in-period https://stock.noler.com/us/stock/chemocentryx-inc/stock-options-forfeitures-and-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/chemocentryx-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/chemocentryx-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/chemocentryx-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/chemocentryx-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/chemocentryx-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/chemocentryx-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/chemocentryx-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/chemocentryx-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/chemocentryx-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/chemocentryx-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/chemocentryx-inc/stockholders-equity-note-subscriptions-receivable https://stock.noler.com/us/stock/chemocentryx-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/chemocentryx-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/chemocentryx-inc/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/chemocentryx-inc/tax-rate-reconciliation-deductions-other https://stock.noler.com/us/stock/chemocentryx-inc/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/chemocentryx-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/chemocentryx-inc/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-percent https://stock.noler.com/us/stock/chemocentryx-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/chemocentryx-inc/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/chemocentryx-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/chemocentryx-inc/tax-withholding-on-stock-awards https://stock.noler.com/us/stock/chemocentryx-inc/total-assets https://stock.noler.com/us/stock/chemocentryx-inc/total-liabilities https://stock.noler.com/us/stock/chemocentryx-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/chemocentryx-inc/total-long-term-debt https://stock.noler.com/us/stock/chemocentryx-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/chemocentryx-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/chemocentryx-inc/utb-decrease-from-settlements https://stock.noler.com/us/stock/chemocentryx-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/chemocentryx-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/chemocentryx-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/chemocentryx-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/chemocentryx-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/chemocentryx-inc/weighted-average-number-of-share-outstanding-basic-and-diluted